Particle.news
Drug Development Cancer Treatment Acquisitions Vaccine Development Mergers and Acquisitions mRNA Technology Market Impact Emerging Companies Diagnostics Royalty Agreements Medical Products Logistics Gene Therapy Active Ingredients Amylyx Pharmaceuticals, Inc. Clinical Trials Biopharmaceutical Companies Biosimilars Market Trends Clinical Research Contract Manufacturing Artificial Intelligence Collaboration Capacity Building Healthcare Partnerships Fermentation Technology Partnerships Clinical Development Research and Development Contract Research Organizations Moderna Prevacus BioNTech Regulatory Approval
The pact underscores Chinese biotech’s rapid rise in global licensing, with Hengrui leading Phase I trials for the COPD asset before GSK’s later-stage development.
